Co-Authors
This is a "connection" page, showing publications co-authored by Pauline Maisonnasse and Roger Le Grand.
Connection Strength
1.655
-
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020 09; 585(7826):584-587.
Score: 0.894
-
Non-human primate models of human respiratory infections. Mol Immunol. 2021 07; 135:147-164.
Score: 0.235
-
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques. Nat Commun. 2021 09 01; 12(1):5215.
Score: 0.060
-
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates. Cell Host Microbe. 2021 09 08; 29(9):1437-1453.e8.
Score: 0.060
-
[COVID-19: Warp Speed vaccines]. Med Sci (Paris). 2021 Aug-Sep; 37(8-9):759-772.
Score: 0.059
-
Predictive Markers of Immunogenicity and Efficacy for Human Vaccines. Vaccines (Basel). 2021 Jun 01; 9(6).
Score: 0.059
-
SARS-CoV-2 viral dynamics in non-human primates. PLoS Comput Biol. 2021 03; 17(3):e1008785.
Score: 0.058
-
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021 03 04; 184(5):1188-1200.e19.
Score: 0.058
-
SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota. Gut Microbes. 2021 Jan-Dec; 13(1):1-19.
Score: 0.058
-
Animal models for COVID-19. Nature. 2020 10; 586(7830):509-515.
Score: 0.057
-
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nat Commun. 2020 08 26; 11(1):4253.
Score: 0.056